A phase II trial of first-line sorafenib in patients with metastatic renal cell carcinoma unwilling to receive or with early intolerance to immunotherapy: SOGUG Study 06-01

2010 ◽  
Vol 12 (7) ◽  
pp. 503-508 ◽  
Author(s):  
Joaquim Bellmunt ◽  
Pablo Maroto-Rey ◽  
José M. Trigo ◽  
Joan Carles ◽  
Vicente Guillem ◽  
...  
Urology ◽  
2004 ◽  
Vol 63 (6) ◽  
pp. 1061-1065 ◽  
Author(s):  
Peter E. Clark ◽  
M.Craig Hall ◽  
Antonius Miller ◽  
Kevin P. Ridenhour ◽  
Diana Stindt ◽  
...  

Cancer ◽  
2011 ◽  
Vol 118 (5) ◽  
pp. 1252-1259 ◽  
Author(s):  
Carlos H. Barrios ◽  
David Hernandez-Barajas ◽  
Michael P. Brown ◽  
Se-Hoon Lee ◽  
Luis Fein ◽  
...  

1994 ◽  
Vol 152 (3) ◽  
pp. 841-845 ◽  
Author(s):  
Julie A. Ellerhorst ◽  
Robert G. Kilbourn ◽  
Robert J. Amato ◽  
Alexander A. Zukiwski ◽  
Elaine Jones ◽  
...  

2010 ◽  
Vol 66 (6) ◽  
pp. 1065-1070 ◽  
Author(s):  
Seiji Naito ◽  
Taiji Tsukamoto ◽  
Michiyuki Usami ◽  
Hiroyuki Fujimoto ◽  
Hideyuki Akaza

Urology ◽  
2008 ◽  
Vol 72 (4) ◽  
pp. 898-902 ◽  
Author(s):  
Shanthi Marur ◽  
James Eliason ◽  
Lance K. Heilbrun ◽  
Brenda Dickow ◽  
Daryn W. Smith ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document